Hospital

The treatment improved lung function at 12 weeks and quality of life at 4 weeks.

The drug is available in 2 formulations, including a weekly injection with a lower dose than previously available as well as a monthly injection.

EUA restriction for hospitalized patients was basis for lawsuit that advanced several arguments.

Comprehensive in-hospital planning, postdischarge follow-up, ongoing support are key.

The attitudes of community-based opioid use disorder treatment center staff toward the emergency department as a site of initiation were varied, with some feeling that emergency department-initiated buprenorphine may attract patients who were not experiencing life-threatening emergencies.

The protozoan intranasal treatment was associated with a strong increase of immune cells within the lung.

Reporting vaccination data to Immunization Information Systems databases can support public health surveillance activities.

Specialty pharmacists—those caring for patients with serious, sometimes life-threatening conditions such as cancer or rheumatologic disease—are not immune from the ongoing labor crisis.

The imaging agent and visualization system will be an adjunct to standard of care to reduce residual cancer in the lumpectomy cavity during initial surgery.

Pharmacists should continue to monitor payer policy changes and reimbursement rates and improve understanding of electronic order entry.

The diagnosis should change from an influenza infection if the patient has gradually increasing chest pain after the original diagnosis.

In neonatal intensive care units, probiotic usage was associated with a decline in necrotizing enterocolitis, but not with sepsis or mortality rates.

The risk of long COVID-19 in females in the least deprived areas was comparable to the risk of males in the most deprived areas.

A barrier in effectively treating HIV has been the latency of infected CD4+ T cells, which are often treatment-resistant and contribute to the persistence nature of the virus.

From 2017 to 2021, Australia did not experience a large increase in infections of serotype 19A across all ethnic and age groups, unlike New Zealand.

Long-term data show that early treatment with ofatumumab decreased confirmed disability worsening in nearly all study patients with relapsing multiple sclerosis.

Avapritinib has been FDA approved for the treatment of advanced systemic mastocytosis since June 2021.

Many patients with post-COVID-19 condition reported perceived cognitive deficits early during their COVID-19 infection as well.

Beremagene geperpavec completely closed severe blistering and wounds in more than half of all patients with dystrophic epidermolysis bullosa with specific mutations.

Understanding causes, consequences proves vital to develop therapies that exploit vulnerabilities of the cancer cells.

The results of a recent study suggest that a testing policy change for C. difficile could decrease the risk of additional infections and the corresponding economic burden on the hospital.

Supportive nurse managers and supervisors as well as nurses’ involvement in organizational governance may help lower hospital-onset Clostridioides difficile infection in acute care hospitals.

Findings suggest that mice derived from and breastfed by immunized mothers were capable of producing anti- pneumococcal surface protein A (PspA) specific antibodies, despite having no direct exposure to PspA.

Treatment with epcoritamab-bysp showed a 61% overall response rate and a 38% complete response rate in heavily pretreated patients with R/R DLBCL.

Delivery, manufacturing concerns hinder green light from US Agency, but European Medicines Agency approves treatment.

Nanoparticles could improve the solubility of drugs, aid in treatment escape from the immune system, and increase the half-life of drugs in the circulatory system against viral lung infections such as influenza, coronavirus, and respiratory syncytial virus.

PCV10 protection is likely to have reduced the incidence of pneumococcal disease among all ages by between 48% and 66%.

Targeted PrEP advertisements with different types of couples and sociodemographic characteristics were more eye-catching, motivating, relatable, and memorable.

Amid various obstacles, health care providers and pharmacists can initiate measures to enhance compensation for pharmacy services in managed care.

In clinical trials of patients with Crohn disease, upadacitinib demonstrated early and long-term symptom relief, as well a visible reduction of damage to the intestinal lining caused by excess inflammation.